Initially, it was reported that SAMHD1 mRNA and protein expression were reduced in peripheral blood mononuclear cells (PBMCs) obtained from patients with Sézary syndrome (SS), an aggressive subtype of cutaneous T-cell lymphoma (CTLC), compared to healthy donors [70]. Here, SAMHD1 is linked to primary cutaneous T-cell non-Hodgkin lymphoma.